View Larger
Key Documents
Allison W. Kurian, M.D., M.Sc.
Academic Appointments
- Assistant Professor - Med Center Line, Medicine - Oncology
- Member, Cancer Center
- Assistant Professor - Med Center Line, Health Research & Policy
Contact Information
-
Clinical Offices
Oncology 875 Blake Wilbur Dr MC 5826 Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 498-5150
- Academic Offices
Personal Information Email Tel (650) 498-6000Administrative Contact Oncology Clinic Tel Work 650-498-6000Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Breast Cancer
- Cancer Genetics
- Medical Oncology
- Breast Cancer Risk
Administrative Appointments
- Scientific Program Committee, Cancer Prevention and Epidemiology, American Society of Clinical Oncology (2011 - 2014)
- Panel on Clinical Guideline Development for Genetic Risk of Breast and Ovarian Cancer, National Comprehensive Cancer Network (2009 - present)
- Program Committee, Professional Development, American Society of Clinical Oncology (2008 - 2011)
- Career Development Subcommittee, American Society of Clinical Oncology (2008 - 2011)
- Associate Director, Stanford Clinical Cancer Genetics Program (2007 - present)
Honors and Awards
- New Clinical Investigator Award, Stanford Cancer Institute (2011)
- Translational Research Award, California Breast Cancer Research Program (2010)
- Jan Weimer Faculty Investigator Award for Breast Cancer Research, Stanford University (2008)
- Physician Faculty Scholars Award, Robert Wood Johnson Foundation (2008)
- Cornelius L. Hopper Research Abstract Award, California Breast Cancer Research Program (2007)
Professional Education
| M.Sc.: | Stanford University, Epidemiology (2006) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2005) |
| Fellowship: | Stanford University School of Medicine CA (2005) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2002) |
| Residency: | Massachusetts General Hospital MA (2002) |
Postdoctoral Advisee
Community & International Work
Scientific Focus
Current Research Interests
My research focuses on the epidemiology, prevention, and outcomes of women's cancers. This work is highly collaborative within the Stanford Divisions of Oncology and Epidemiology, with the Stanford Departments of Radiology, Obstetrics and Gynecology, Pathology, and Biomedical Informatics, and with the Cancer Prevention Institute of California.
Ongoing projects include studies of racial/ethnic differences in hereditary breast and ovarian cancer, early-phase chemoprevention and treatment trials, and computer-based simulation modeling to evaluate new approaches to cancer screening and prevention.
Clinical Trials
- A Randomized Controlled Trial using Novel Markers to Predict Malignancy in Elevated-Risk Women Recruiting
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples Recruiting
- Phase I MVA-BN�-HER2 Vaccine in HER-2+ Breast CA Following Adjuvant Therapy Recruiting
- Phase II Gemcitabine, Carboplatin & PARP Inhibitor BSI-201 in Neoadjuvant Tx of Triple-Neg Breast CA No longer recruiting
- A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer Active, not recruiting
Publications
- Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 2010; (6): R99
- Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol. 2010; (2): 222-31
- Second primary breast cancer occurrence according to hormone receptor status. J Natl Cancer Inst. 2009; (15): 1058-65
- Performance of BRCA1/2 mutation prediction models in Asian Americans. J Clin Oncol. 2008; (29): 4752-8
- A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer. J Clin Oncol. 2007; (6): 634-41
Help